+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy

The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy

Journal of Clinical Immunology 27(2): 181-192

Autoantibodies against alpha-enolase, a glycolytic enzyme, have been frequently associated with visual loss and retinal degeneration in patients with autoimmune and cancer-associated retinopathy; however their role in the pathogenicity of retinopathy has not been fully explained. Thus, we examined the causative role of anti-enolase antibodies on retinal cells. In the in vitro studies reported here, we found that Enol-1 monoclonal antibody against alpha-enolase significantly inhibited the catalytic function of enolase, which resulted in the depletion of glycolytic ATP. Enol-1 significantly increased intracellular Ca(2+), which led to Bax translocation to the mitochondria, and the release of cytochrome c into the cytoplasm--events that correlated with the initiation of apoptosis. Normal IgG did not induce intracellular calcium or reduce cytosolic ATP. L-type voltage-gated calcium channel blockers (nifedipine, D-cis-diltiazem, and verapamil) were effective in blocking the Ab-induced intracellular Ca(2+) rise and induction of Bax. Based on these findings we propose that chronic access of autoantibodies to the retina results in the inhibition of enolase catalytic function, depletion of ATP, and elevation in intracellular Ca(2+), leading to deregulation of glycolysis in retinal neurons and their destruction.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 013025971

Download citation: RISBibTeXText

PMID: 17235687

DOI: 10.1007/s10875-006-9065-8

Related references

Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy. Journal of Autoimmunity 23(2): 161-167, 2004

A unique case of autoimmune retinopathy associated with anti-alpha-enolase antibodies. Case Reports in Ophthalmological Medicine 2011: 371324, 2011

Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells. Journal of Autoimmunity 11(6): 671-677, 1998

Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. Journal of Rheumatology 27(1): 109-115, 2000

Anti-γ-enolase autoimmune retinopathy manifesting in early childhood. Archives of Ophthalmology 128(12): 1590-1595, 2010

Anti-NH2-terminal of alpha-enolase (NAE) autoantibodies. Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl. 6): 648-650, 2010

Characteristics of anti-retinal autoantibodies in patients with autoimmune retinopathy. IOVS 42(4): S570, 2001

Cytotoxic and apoptotic effect of anti-retinal autoantibodies of autoimmune retinopathy. FASEB Journal 14(6): A1107, 2000

Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients. Japanese Journal of Clinical Oncology 40(7): 663-669, 2010

Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung. American Journal of Ophthalmology 139(4): 746-747, 2005

The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clinical Immunology and Immunopathology 78(2): 120-129, 1996

Unique epitopes for carbonic anhydrase II autoantibodies related to autoimmune retinopathy and cancer-associated retinopathy. Experimental Eye Research 147: 161-168, 2016

Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Investigative Ophthalmology and Visual Science 34(9): 2626-2633, 1993

Anti-retinal autoantibodies-positive autoimmune retinopathy in cytomegalovirus-positive anterior uveitis. British Journal of Ophthalmology 94(3): 380-381, 2010

Polyreactivity of disease-associated anti-RBC IgG autoantibodies of patients with warm autoimmune haemolytic anaemia and natural anti-RBC IgG autoantibodies of healthy individuals. Scandinavian Journal of Immunology 52(2): 190-199, 2000